Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if MDXG is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
28 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
228 filers reported a long position in MDXG for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Essex Woodlands Management, Inc. | $108.6M | 28.2M | Unchanged |
| BlackRock, Inc. | $46.8M | 12.2M | +2% |
| Trigran Investments, Inc. | $27.6M | 7.2M | 0% |
| STATE STREET CORP | $21.5M | 5.6M | +10.3% |
| VANGUARD CAPITAL MANAGEMENT LLC | $20M | 5.2M | +0.4% |
| Nantahala Capital Management, LLC | $18.4M | 4.8M | +40.3% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $15.7M | 4.1M | +19.4% |
| GEODE CAPITAL MANAGEMENT, LLC | $12.1M | 3.1M | +9.1% |
| GOLDMAN SACHS GROUP INC | $10.3M | 2.7M | +124.8% |
| AQR CAPITAL MANAGEMENT LLC | $9.5M | 2.5M | +170.3% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.